A class action lawsuit has been filed against Honeywell Aerospace by investors who bought stock between June 29 and September 1, 2026. The suit alleges the company made misleading statements about supply constraints and failed to disclose an investigation related to cybersecurity compliance in a Department of Defense contract. Honeywell's stock fell sharply after it reported a 70% drop in net income for Q2 2026 and after agreeing to pay over $2 million to settle False Claims Act allegations. Investors may seek to be lead plaintiffs by November 23, 2026.
The class action lawsuit involving Honeywell Aerospace Inc. provides context for readers interested in industrial stocks. For readers following Industrials-sector US stocks on Pluang, here is the market snapshot as of Sep 25, 2026 03:13 WIB: out of 93 priced stocks, 40 rose and 53 fell. Notable movers include Rocket Lab USA Inc (RKLB) at USD 73.79 with a 1-day change of +4.95% and a typical hold time of 27 days, FuelCell Energy Inc (FCEL) at USD 16.40 with a 1-day change of -4.54% and 100% buy order activity, and FedEx Corporation (FDX) at USD 279.82 with a 1-day change of -4.01% and 96% buy order activity.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...
Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...
